UNSPSC 51152117: Meprobamate/tridihexethyl

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA802. This VA Drug Class (GA802) classifies this compound as belonging to the group ANTIMUSCARINIC/ANTIPASMODIC COMBINATIONS.

UNSPSC 51152117 Meprobamate/tridihexethyl is a Commodity code that does not align with recent state and local procurement activity posted under it. The two opportunities tagged to this code involve naloxone procurement (an opioid antagonist used in overdose response) and direct-to-manufacturer prescription program capabilities (pharmacy benefit management), neither of which falls within the scope of meprobamate, a muscle relaxant and anxiolytic agent, or tridihexethyl, an anticholinergic compound. The mismatch suggests tagging inconsistency in the source records rather than active state or local buying of the nominal pharmaceutical ingredients under this code.

The Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with E-Verify and workers' compensation insurance requirements. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013, April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager channels. These solicitations reflect state and local demand for pharmaceutical products and pharmacy program innovation, but the code itself shows no verifiable recent activity in meprobamate or tridihexethyl procurement. Firms pursuing pharmaceutical supply contracts with state and local health agencies should monitor codes aligned with actual drug procurement rather than this mistagged category.